Welcome to our dedicated page for Agilent Technologies news (Ticker: A), a resource for investors and traders seeking the latest updates and insights on Agilent Technologies stock.
Agilent Technologies Inc. (NYSE: A) is a global company in analytical and clinical laboratory technologies, and its news flow reflects activity across life sciences, diagnostics, and applied markets. Company announcements highlight how Agilent’s instruments, software, services, and expertise are used to help customers bring great science to life, as well as how it manages its financial performance and corporate governance.
On this page, readers can follow Agilent news related to earnings results, product introductions, regulatory-focused solutions, capital allocation, and investor events. Recent releases include quarterly and full-year financial results, with details on revenue, net income, and segment performance for the Life Sciences and Diagnostics Markets Group, the Agilent CrossLab Group, and the Applied Markets Group. These updates often include management commentary on business conditions and outlook.
Agilent’s news also covers product and technology developments. For example, the company has announced 21 CFR Part 11 compliance software for the xCELLigence RTCA eSight system, designed to support use in GMP-regulated manufacturing and quality control environments by adding secure user authentication, electronic signatures, and audit trails. Another announcement introduced Agilent Altura Ultra Inert HPLC Columns, described as high performance liquid chromatography columns suited for biotherapeutics applications such as peptide GLP-1 and oligonucleotide therapeutic development and quality control.
Investors and analysts can also find updates on capital markets activities, such as cash dividend declarations on Agilent’s common stock, and notices of participation in healthcare and investor conferences. Governance-related news, including leadership transitions and executive appointments, is communicated through press releases and related SEC filings. Bookmarking this page allows users to review Agilent’s ongoing communications about its operations, technologies, financial performance, and corporate developments in one place.
Agilent Technologies will showcase its latest mass spectrometry innovations at the 72nd ASMS Conference, from June 2-6, 2024, in Anaheim, CA. Agilent plans to unveil new products like the 6495D LC/TQ, capable of detecting analytes at parts per quadrillion levels, and the Revident LC/Q-TOF, a hybrid mass spectrometer for high-resolution analysis. Agilent’s offerings aim to enhance lab efficiency and data insights for diverse applications such as food safety and metabolomics. The company will host various events and sessions during the conference, inviting attendees to learn more about their cutting-edge solutions.
Agilent Technologies (NYSE: A) announced that CFO Bob McMahon will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York City. The event will take place on Wednesday, June 5, at 8:30 a.m. EDT. Interested parties can listen to the live or recorded session via the Agilent Investor Relations website. The recording will be accessible for 90 days.
Agilent Technologies announced the presentation of its Solutions Innovation Research Awards to Professors Richard Robinson of Cornell University and Xingchen Ye of Indiana University. These awards recognize their contributions to advanced materials research, specifically in electrocatalysis and nanomaterials. Professor Robinson's work focuses on high-entropy nanoparticles and their applications in sustainable energy systems. He received a one-year loan of an Agilent Cary 630 FTIR system. Professor Ye specializes in nanomaterials for fuel-cell and semiconductor applications. He received a one-year loan of an Agilent Cary 5000 UV-Vis-NIR spectrophotometer. Agilent supports university research through its SIRA program, aiming to solve scientific problems with innovative use of its products.
Agilent Technologies Inc. (NYSE: A) will announce its second-quarter fiscal year 2024 financial results on May 29. The company will hold a conference call to discuss the results at 1:30 p.m. PT. Investors can join the call via the company's investor relations website.
Padraig McDonnell has assumed the role of Agilent CEO, succeeding Mike McMullen. McDonnell is the fourth CEO in Agilent's history. He brings a proven record of success, having served as president of the Agilent CrossLab Group (ACG) and chief commercial officer. McDonnell's leadership skills and customer focus are expected to drive Agilent's growth and success in the future.
Agilent Technologies Inc. (NYSE: A) has introduced the NovoCyte Opteon Spectral Flow Cytometer, a cutting-edge system that revolutionizes flow cytometry by offering advanced spectral capabilities and user-friendly design. This new addition to the NovoCyte family features three to five lasers, up to 73 detectors, and the ability to analyze over 40 markers simultaneously, providing researchers with unprecedented precision and flexibility in flow cytometry assays. The NovoCyte Opteon will be officially unveiled at the CYTO 2024 Conference in May 2024, marking a decade of innovation in the NovoCyte platform.
Agilent Technologies, Inc. (NYSE: A) has appointed Simon May as the president of the Diagnostics and Genomics Group (DGG). May, previously from Bio-Rad Laboratories, brings a wealth of experience to Agilent. He will be joining the company on May 6th. The CEO-elect, Padraig McDonnell, expressed excitement about May's technical expertise, experience, and focus on strategy. May's background includes roles at Bio-Rad and Thermo Fisher Scientific, with academic credentials from the University of Liverpool.
Summary not available.
Summary not available.
Summary not available.
FAQ
What is the current stock price of Agilent Technologies (A)?
What is the market cap of Agilent Technologies (A)?
